A review by Shi et al in 2006 describes its immunobiology specifically in T cells [33], and more recently a number of studies have demonstrated the advantages of monitoring T cells expressing GM-CSF in the context of infection [34], [35], and vaccine responses to bacterial [36] and tumor antigens [37]. The gene discussed is CSF2; the disease is neoplasm.